SMITHKLINE BEECHAM's EMINASE WILL BE AVAILABLE AFTER JAN. 1, BACKED BY 1,200 BEECHAM, SK&F AND UPJOHN SALES REPS; THROMBOLYTIC APPROVED ON NOV. 27